https://www.fool.com/investing/2017/05/05/why-immunomedics-mercadolibre-and-pearson-jumped-t.aspx
Why Immunomedics, MercadoLibre, and Pearson Jumped Today | The Motley Fool
May 5, 2017 - These stocks helped lead the market higher. Find out why.
the motley foolimmunomedicsmercadolibrepearsonjumped
https://www.pymnts.com/cpi-posts/gilead-focuses-on-cancer-treatments-with-21b-immunomedics-deal/
Gilead Focuses On Cancer Treatments With $21B Immunomedics Deal | PYMNTS.com
Sep 15, 2020 - Gilead Sciences Inc. agreed to acquire Immunomedics Inc. for about $21 billion, a substantial premium for the maker of a promising breast-cancer therapy, and...
cancer treatmentsgileadfocusesimmunomedicsdeal
https://www.biospace.com/immunomedics-s-breast-cancer-drug-wins-breakthrough-tag-from-the-fda
Immunomedics's Breast Cancer Drug Wins Breakthrough Tag from the FDA - BioSpace
breast cancerfrom theimmunomedicsdrugwins
https://www.biocentury.com/article/61129/immunomedics-regulatory-update
BioCentury - Immunomedics regulatory update
IMMU received two patents and a notice of allowance from the Japanese Patent Office covering its imaging and therapy technologies. Patent No. 1,996,023 cov...
regulatory updateimmunomedics